CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

Cannabis Bioscience International Holdings, Inc.

CBIH

US16948K1060

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 14:41:48 31/05/2024 BST			5-day change	1st Jan Change
0.0006 ^USD	-14.29%		-.--%	-25.00%

04-22	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	CI
03-18	Cannabis Bioscience International Holdings, Inc. announced that it has received $0.05 million in funding from 1800 Diagonal Lending, LLC	CI

Cannabis Bioscience International Holdings, Inc. announced that it has received $0.05 million in funding from 1800 Diagonal Lending, LLC

March 17, 2024

On March 18, 2024, Cannabis Bioscience International Holdings, Inc. closed the transaction.

Latest news about Cannabis Bioscience International Holdings, Inc.

Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	04-22	CI
Cannabis Bioscience International Holdings, Inc. announced that it has received $0.05 million in funding from 1800 Diagonal Lending, LLC	03-17	CI
Cannabis Bioscience International Holdings, Inc. announced that it expects to receive $0.05 million in funding from 1800 Diagonal Lending, LLC	03-13	CI
Cannabis Bioscience International Holdings Elects Brian Cuban to its Advisory Board Member	02-25	CI
Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	01-25	CI
Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023	11-13	CI
Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2023	27/09/23	CI

Chart Cannabis Bioscience International Holdings, Inc.

Duration

Period

Chart Cannabis Bioscience International Holdings, Inc.

More charts

Cannabis Bioscience International Holdings, Inc. provides educational and other services to the cannabis industry. The Company provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The Companyâs segments include Pharmacology University Business and Alpha Research Business. Through the Pharmacology University Business, the Company provides knowledge and promotes professionalism in the rapidly growing worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. These trials have included drugs relating to diseases in the areas of asthma, allergies, renal disorders, neurology disorders, cardiac and vascular disorders and others.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.	-25.00%	6.26M
MODERNA, INC.	+43.36%	54.63B
IQVIA HOLDINGS INC.	-5.31%	39.92B
ICON PUBLIC LIMITED COMPANY	+14.75%	26.86B
CELLTRION, INC.	-12.56%	26.22B
ALNYLAM PHARMACEUTICALS, INC.	-22.45%	18.78B
UNITED THERAPEUTICS CORPORATION	+25.12%	12.21B
BIO-TECHNE CORPORATION	+0.04%	12.16B
MEDPACE HOLDINGS, INC.	+26.04%	11.94B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-11.83%	10.74B